| 1 |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
|
| 2 |
Charlton M, Chioreso C, Pagedar N. Treatment selection in advanced oropharyngeal cancer: a surveillance, epidemiology and end results (SEER) patterns of care (POC) analysis[J]. Annals Epidemiol, 2015, 25(9):704-705.
|
| 3 |
Zhang S, Cui X. WHO/ICO information centre on HPV and cervical cancer:un nuevo recurso en la Web[J]. Fmc Formación Médica Continuada En Atención, 2009, 16(9):55-57.
|
| 4 |
Quick KD, de Koning MN, van DoornL J, et al. HPV genotping and HPV-16 variant analysis in glandular and squamous neoplastic leaions of the uterine cervix[J]. Gynecol Oncol, 2010, 117(2):297-301.
|
| 5 |
Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of tumors of female reproductive organs[M]. Lyon: International Agency for Research on Cancer, 2014: 176-178.
|
| 6 |
Yu MC, Austin RM, Liu J, et al. The role of high-risk human papilloma virus testing in the surveillance of cervical cancer after treatment[J]. Arch Pathol Lab Med, 2015, 139(11):1437-1440.
|
| 7 |
An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma:a population-based study[J]. Mod pathol, 2005, 18(4):528-534.
|
| 8 |
Miller RA, Mody DR, Tams KC, et al. Glandular lesions of the cervix in clinical practice[J]. Arch Pathol Lab Med, 2015, 139(11):1431-1436.
|
| 9 |
Mark S, Nicolas W, SholomW, et al. Human papillomavirus testing in the prevention of cervical cancer[J]. Natl Cancer Inst, 2011, 103(5):368-383.
|
| 10 |
Young RH, ScullyRE.Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases[J]. Cancer, 1989, 63(9):1773-1779.
|
| 11 |
Kusanagi Y, Kojima A, Mikami Y, et al. Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype[J]. Am J Pathol, 2010, 177(5):2169-2175.
|
| 12 |
Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: animmunohitochemical analysis with molecular detection of human papililomavirus[J]. Am J Surg Pathol, 2011, 35(5):633-648.
|
| 13 |
Silver SA, Devouassoux-Shisheboran M, Mezztti TP, et al. Mesonephrio adenocarcinomas of the uterine cervix:a study of 11 cases with immunohistochemical findings[J]. Am J Surg Pathol, 2001, 25(3):379-387.
|
| 14 |
Mitchel HS. Outcome after a cytological prediction of glandular abnormality[J]. Aust N Z J Obstet Gynaecol, 2004, 44(4):436-440.
|
| 15 |
ZainoRJ. Symposium part 1:adenocarcinoma in situ, glandulardysplasia, and early invasive adenocarcinoma of the uterine cervix[J]. Int J Gynecol Pathol, 2002, 21(4):314-326.
|
| 16 |
Park JJ, SunD, QuadeBJ, et al. Stratifiedmucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia？[J]. Am J Surg Pathol, 2000, 24(11):1414-1419.
|